@article{3220097,
    title = "Lupus-like disease and progressive multifocal leukoencephalopathy following etanercept treatment: just a coincidence?",
    author = "Papadopoulos, V.E. and Velonakis, G. and Argyrakos, T. and Anagnostouli, M. and Stefanis, L. and Mavragani, C.P. and Evangelopoulos, M.-E.",
    journal = "Clinical and Experimental Rheumatology",
    year = "2022",
    volume = "40",
    number = "3",
    pages = "671-672",
    publisher = "Clinical and Experimental Rheumatology S.A.S.",
    issn = "0392-856X, 1593-098X",
    doi = "10.55563/CLINEXPRHEUMATOL/CFG3TK",
    keywords = "CD4 antigen;  CD8 antigen;  choline;  etanercept;  hydroxychloroquine;  immunoglobulin G;  lactic acid;  methylprednisolone;  mirtazapine;  steroid;  tumor necrosis factor inhibitor, aged;  aphasia;  apraxia;  behavior change;  brain damage;  case report;  CD4+ T lymphocyte;  clinical article;  cognitive defect;  disorientation;  drug dose reduction;  drug withdrawal;  female;  hair loss;  hemianopia;  human;  immunophenotyping;  inflammation;  Letter;  lupus like syndrome;  mass spectrometry;  medical history;  photosensitivity;  progressive multifocal leukoencephalopathy;  psoriatic arthritis"
}